Povidone-iodine pharmacokinetics and study design
Jagger Koerner1, Andrzej Grzybowski2
1Department of Ophthalmology, Wake Forest University, Winston Salem, USA. jaggerkoerner@gmail.com.
BMC Ophthalmology
|January 19, 2020
Summary
Povidone iodine (PI) showed limited bactericidal activity against respiratory flora in a specific agar plate experiment. Methodological differences may explain why these findings differ from typical clinical observations.
Area of Science:
- Microbiology
- Antimicrobial Susceptibility Testing
- Infectious Diseases
Background:
- Investigated the bactericidal efficacy of povidone iodine (PI) against respiratory flora using an agar plate method.
- Focused on specific concentrations and experimental conditions that may influence PI's antimicrobial activity.
Discussion:
- The study design and pharmacokinetic properties of PI solution precluded the effectiveness of dilute PI.
- Results contrast with previous agar plate experiments due to subtle yet significant methodological variations.
Key Insights:
- Agar plate experiments may not fully represent in vivo clinical scenarios for antimicrobial efficacy.
- Methodological standardization is crucial for reproducible and comparable results in antimicrobial research.
Outlook:
- Further research is needed to reconcile in vitro findings with clinical outcomes for povidone iodine.
- Exploring standardized methodologies for evaluating antiseptics like PI is recommended for future studies.
Related Concept Videos
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
152
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
152
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
101
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
101
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
108
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
108
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
617
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
617
01:20Measurement of Bioavailability: Pharmacodynamic Methods
173
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
173
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
236
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
236